Skip to main content

Table 1 Characteristics of patient participants (N = 120)

From: Validation of the Japanese version of the barriers questionnaire II in cancer pain management: a cross-sectional study

 

N = 120

Demographics

n

(%)

Age

30–39

7

(5.8)

(56.6 ± SD 11.57)

40–49

28

(23.4)

 

50–59

33

(27.5)

 

60–69

30

(25.0)

 

70–89

22

(18.3)

Sex

Male

25

(20.8)

Female

95

(79.2)

Highest education level

Middle/High school

32

(26.7)

Vocational school/jr. college

43

(35.8)

University/graduate school

45

(37.5)

Disease

n

(%)

Diagnosis

Breast

85

(70.8)

Digestive system

22

(18.3)

Urological

11

(9.2)

Other

2

(1.7)

Stage

Stage IV

111

(92.5)

Stage IIIc

6

(5.0)

Stage IIIb

3

(2.5)

Metastasis

Yes

110

(91.7)

(Bone metastasis)

67

(57.5)

No

10

(8.3)

PS a

0

73

(60.8)

1

40

(33.3)

2

7

(5.8)

Drugs used

No analgesics usedb

46

(38.3)

Non-opioids

57

(46.6)

Weak opioids

7

(5.8)

Strong opioids

26

(21.7)

  1. a Eastern Cooperative Oncology Group performance status
  2. b This category includes “Analgesics prescribed but patient has elected not to use,” “Experiencing pain but no analgesics prescribed,” and “Had no pain on the day of the survey”